Former MP to chair Australian Advisory Council on the Medicinal Use of Cannabis

23 December 2016

Medical practitioner and politician Andrew Southcott will chair the new Australian Advisory Council on the Medicinal Use of Cannabis.

Dr Southcott is a former Member of Parliament who held the positions of Shadow Parliamentary Secretary for Health and Wellbeing and Regional Health Services, and Shadow Parliamentary Secretary for Primary Healthcare.

The Australian government has described the new council as a vital component of its Medicinal Cannabis Scheme, which was the result of extensive consultation between the federal government and state and territory authorities in the development of regulations and security protocols for the cultivation, production and manufacture of medicinal cannabis.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK